Evofem Biosciences Q1 EPS $(0.04), Sales $899.000K Up From $845.000K YoY

Evofem Biosciences, Inc.

Evofem Biosciences, Inc.

EVFM

0.00

Evofem Biosciences (OTC: EVFM) reported quarterly losses of $(0.04) per share. The company reported $899.000 thousand in sales this quarter. This is a 6.39 percent increase over sales of $845.000 thousand the same period last year.